New Key Statistics Module, Z-Score and F-Score
NAS:URGN Key Ratios
Market Cap $ M | 596.34 |
Enterprise Value $ M | 453.50 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 19.24 |
Price/Sales | 5.78 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 85.00 |
EPS (TTM) $ | -3.22 |
Beneish M-Score | -2.68 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 9.50 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -4.71 |
EV-to-EBITDA | -4.78 |
PEG | -- |
Shares Outstanding M | 42.11 |
Net Margin (%) | -133.61 |
Operating Margin % | -93.74 |
Pre-tax Margin (%) | -128.98 |
Quick Ratio | 7.93 |
Current Ratio | 8.15 |
ROA % (ttm) | -59.80 |
ROE % (ttm) | -- |
ROIC % (ttm) | -332.91 |
Dividend Yield % | -- |
Altman Z-Score | -2.06 |
URGN Number of Guru Trades
URGN Volume of Guru Trades
Gurus Latest Trades with NAS:URGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:URGN is held by these investors
Total 1
UroGen Pharma Ltd Insider Transactions
No Available Data
News about NAS:URGN
Total 0- 1